𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic value of erb-B2 and myc amplification in breast cancer imprints

✍ Scribed by Ulf Lönn; Sigrid Lönn; Bo Nilsson; Björn Stenkvist

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
901 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-myc amplification is an independent pr
c-myc amplification is an independent prognostic factor in postmenopausal breast cancer
✍ Åke Borg; Bo Baldetorp; Mårten Fernö; Håkan Olsson; Helgi Sigurdsson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 681 KB

## Abstract The c‐__myc__ proto‐oncogene was analyzed in 311 cases of primary breast cancer, in 8% of which it was found to be amplified, usually at moderately increased copy number (2‐5 copies). The adjacent pvt gene was co‐amplified with c‐__myc__ in all tumors analyzed. C‐__myc__ amplification w

C-ERB-B2/INT-2 amplification appears fas
C-ERB-B2/INT-2 amplification appears faster in breast-cancer patients receiving second-line endocrine treatment
✍ Ulf Lönn; Sigrid Lönn; Henrik Ingelman-Sundberg; Bo Nilsson; Björn Stenkvist 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 449 KB

We have examined the appearance of c-erb-bz and int-2 amplification in 2 different groups of breast-cancer patients. The groups differed with regard to their clinical status in that one group was receiving first-line endocrine treatment (tamoxifen) whereas the second was receiving second-line endoc

Prognostic value of hormone receptors in
Prognostic value of hormone receptors in breast cancer
✍ Tadaoki Morimoto; Kansei Komaki; Hiroyuki Yamamoto; Takashi Yamakawa; Takashi Ta 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

The aim of this study was to establish the role of estrogen receptor (ER) and progesterone receptor (PgR) as prognostic indicators for early recurrence and survival. In all, among breast cancer patients, 166 patients who had undergone radical or extended radical mastectomy were studied. These patien

Prognostic and predictive value of HER2/
Prognostic and predictive value of HER2/neu oncogene in breast cancer
✍ Shahla Masood; Marilyn M. Bui 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

## Abstract Assessment of __HER2/neu__ oncogene has been used as both a prognostic and predictive marker for breast cancer. However, the choice of the best method to assess the status of __HER2/neu__ oncogene in breast cancer tissue remains controversial. A variety of techniques are available to de

int-2 Amplification in breast cancer: As
int-2 Amplification in breast cancer: Association with decreased survival and relationship to amplification of c-erbb-2 and c-myc
✍ J. A. Henry; C. Hennessy; D. L. Leveit; T. W. J. Len Nard; B. R. Westley; F. E. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 778 KB

Amplification of the int-2 oncogene was measured in a series of breast tumours and related to amplification of the c-myc and c-erbB-2 oncogenes, histopathological features and relapse-free and overall survival. int-2 was amplified in I I%, c-myc in 20% and c-erbB-2 in 27% of the tumours assessed. in